John Feussner to Cost-Benefit Analysis
This is a "connection" page, showing publications John Feussner has written about Cost-Benefit Analysis.
Connection Strength
0.244
-
A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res. 1993 Apr; 28(1):97-121.
Score: 0.093
-
The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care. 2006 Jan; 44(1):91-5.
Score: 0.056
-
The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy. 1998 Mar-Apr; 18(2):327-32.
Score: 0.033
-
Screening for colon cancer. Is it worth the expense? N C Med J. 1993 Dec; 54(12):634-8.
Score: 0.024
-
Cost effectiveness analysis of early zidovudine treatment of HIV infected patients. BMJ. 1993 Nov 20; 307(6915):1322-5.
Score: 0.024
-
Veterans Administration and ambulatory care: the "low-priority" veteran. South Med J. 1984 Apr; 77(4):489-93.
Score: 0.012